Related Experiment Video
Updated: Nov 26, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial
Hao-Hong Shi1, Hai-E Liu1, Xing-Jing Luo2
1Department of Anesthesia, Children's Hospital of Fudan University, Shanghai 201102, China.
Abstract:
The N-myc downstream regulated gene (NDRG) family members are dysregulated in several tumors. Functionally, NDRGs play an important role in the malignant progression of cancer cells. However, little is known about the potential implications of NDRG4 in pancreatic ductal adenocarcinoma (PDAC). The aim of the current study was to elucidate the expression pattern of NDRG4 in PDAC and evaluate its potential cellular biological effects. Here, we firstly report that epigenetic-mediated silencing of NDRG4 promotes PDAC by regulating mitochondrial function. Data mining demonstrated that NDRG4 was significantly down-regulated in PDAC tissues and cells. PDAC patients with low NDRG4 expression showed poor prognosis. Epigenetic regulation by DNA methylation was closely associated with NDRG4 down-regulation. NDRG4 overexpression dramatically suppressed PDAC cell growth and metastasis. Further functional analysis demonstrated that up-regulated NDRG4 in SW1990 and Canpan1 cells resulted in attenuated mitochondrial function, including reduced ATP production, decreased mitochondrial membrane potential, and increased fragmented mitochondria. However, opposite results were obtained for HPNE cells with NDRG4 knockdown. These results indicate that hypermethylation-driven silencing of NDRG4 can promote PDAC by regulating mitochondrial function and that NDRG4 could be as a potential biomarker for PDAC patients. [BMB Reports 2020; 53(12): 658-663].
Insights
Epigenetic silencing of NDRG4 promotes pancreatic cancer by impairing mitochondrial function. Restoring NDRG4 suppresses tumor growth and metastasis, suggesting NDRG4 as a potential biomarker for pancreatic ductal adenocarcinoma (PDAC).
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- N-myc downstream regulated gene (NDRG) family members are implicated in cancer progression.
- The role of NDRG4 in pancreatic ductal adenocarcinoma (PDAC) remains largely unexplored.
Purpose of the Study:
- To investigate the expression pattern of NDRG4 in PDAC.
- To evaluate the cellular biological effects of NDRG4 in PDAC.
- To elucidate the mechanism of NDRG4 dysregulation in PDAC.
Main Methods:
- Data mining of PDAC tissues and cell lines.
- Analysis of DNA methylation patterns.
- Overexpression and knockdown studies of NDRG4.
- Assessment of mitochondrial function (ATP production, membrane potential, morphology).
Main Results:
- NDRG4 is significantly downregulated in PDAC tissues and cells, associated with poor prognosis.
- DNA methylation-driven hypermethylation correlates with NDRG4 downregulation.
- NDRG4 overexpression suppresses PDAC cell growth and metastasis.
- Upregulated NDRG4 attenuates mitochondrial function, leading to reduced ATP production and increased mitochondrial fragmentation.
Conclusions:
- Epigenetic silencing of NDRG4 promotes PDAC progression by regulating mitochondrial function.
- NDRG4 acts as a tumor suppressor in PDAC.
- NDRG4 is a potential prognostic biomarker for PDAC patients.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs

